Search for other papers by Nese Cinar in
Google Scholar
PubMed
Search for other papers by Alper Gurlek in
Google Scholar
PubMed
subclinical hypothyroid patients No significant difference in ADP levels between the groups 53 controls ↑ ADP after normalization of thyroid status ↑, Increase; ↓, decrease; ↔, no change; ADP, adiponectin; fT 4 , free thyroxine; fT 3 , free triiodothyronine
Search for other papers by Nadia Sawicka-Gutaj in
Google Scholar
PubMed
Search for other papers by Ariadna Zybek-Kocik in
Google Scholar
PubMed
Search for other papers by Michał Kloska in
Google Scholar
PubMed
Search for other papers by Paulina Ziółkowska in
Google Scholar
PubMed
Search for other papers by Agata Czarnywojtek in
Google Scholar
PubMed
Search for other papers by Jerzy Sowiński in
Google Scholar
PubMed
Search for other papers by Dorota Mańkowska-Wierzbicka in
Google Scholar
PubMed
Search for other papers by Marek Ruchała in
Google Scholar
PubMed
achieved ( 7 , 24 ). Interestingly, improvement in muscle strength has been observed even after the restoration of thyroid function in subclinical hyperthyroidism ( 24 ). Observed muscle weakness in hyperthyroid patients mainly results from changes in
Search for other papers by Satoshi Higuchi in
Google Scholar
PubMed
Department of Advanced MRI Collaboration Research, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan
Search for other papers by Hideki Ota in
Google Scholar
PubMed
Department of Radiology, The University of British Columbia, Vancouver, Canada
Search for other papers by Yuta Tezuka in
Google Scholar
PubMed
Search for other papers by Kazumasa Seiji in
Google Scholar
PubMed
Department of Radiology, The University of British Columbia, Vancouver, Canada
Search for other papers by Hidenobu Takagi in
Google Scholar
PubMed
Search for other papers by Jongmin Lee in
Google Scholar
PubMed
Search for other papers by Yi-Wei Lee in
Google Scholar
PubMed
Department of Radiology, The University of British Columbia, Vancouver, Canada
Search for other papers by Kei Omata in
Google Scholar
PubMed
Department of Radiology, The University of British Columbia, Vancouver, Canada
Search for other papers by Yoshikiyo Ono in
Google Scholar
PubMed
Search for other papers by Ryo Morimoto in
Google Scholar
PubMed
Search for other papers by Masataka Kudo in
Google Scholar
PubMed
Division of Clinical Hypertension, Endocrinology and Metabolism, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan
Search for other papers by Fumitoshi Satoh in
Google Scholar
PubMed
Search for other papers by Kei Takase in
Google Scholar
PubMed
patients, the ones with APA, with higher hormonal activity than those with BHA, should also have higher cardiac risk, even in the absence of clinical symptoms. The demonstration of subclinical cardiac risk in APA patients by CMR could support the clinical
Search for other papers by Simona Censi in
Google Scholar
PubMed
Search for other papers by Laura Salmaso in
Google Scholar
PubMed
Search for other papers by Filippo Ceccato in
Google Scholar
PubMed
Pediatric Endocrinology Unit, Department of Women's and Children's Health, Padua University Hospital, Padova, Italy
Search for other papers by Jacopo Manso in
Google Scholar
PubMed
Search for other papers by Ugo Fedeli in
Google Scholar
PubMed
Search for other papers by Mario Saia in
Google Scholar
PubMed
Search for other papers by Caterina Mian in
Google Scholar
PubMed
associated with nodular goiter is quite well understood and thus the decrease in nodular goiter incidence with the improvement of iodine status is expected. The mechanism is slow and could take decades to go from euthyroidism to subclinical hyperthyroidism
Search for other papers by Hana Vítková in
Google Scholar
PubMed
Department of Gynaecology, Obstetrics and Neonatology, First Faculty of Medicine Charles University and General University Hospital in Prague, Prague, Czech Republic
Search for other papers by Kateřina Anderlová in
Google Scholar
PubMed
Search for other papers by Jan Krátký in
Google Scholar
PubMed
Search for other papers by Radovan Bílek in
Google Scholar
PubMed
Search for other papers by Drahomíra Springer in
Google Scholar
PubMed
Search for other papers by Felix Votava in
Google Scholar
PubMed
Search for other papers by Tomáš Brutvan in
Google Scholar
PubMed
Search for other papers by Adéla Krausová in
Google Scholar
PubMed
Search for other papers by Kristýna Žabková in
Google Scholar
PubMed
Search for other papers by Eliška Potluková in
Google Scholar
PubMed
Search for other papers by Jan Jiskra in
Google Scholar
PubMed
between thyroid autoimmunity and gestational diabetes mellitus in euthyroid women . European Thyroid Journal 2022 11 . ( https://doi.org/10.1530/ETJ-21-0142 ) 7 Tudela CM Casey BM McIntire DD & Cunningham FG . Relationship of subclinical
Endocrine Disease Unit, University-Hospital of Padova, Padova, Italy
Department of Neuroscience DNS, University of Padova, Padova, Italy
Search for other papers by Filippo Ceccato in
Google Scholar
PubMed
Search for other papers by Elisa Selmin in
Google Scholar
PubMed
Laboratory Medicine, University-Hospital of Padova, Padova, Italy
Search for other papers by Giorgia Antonelli in
Google Scholar
PubMed
Endocrine Disease Unit, University-Hospital of Padova, Padova, Italy
Department of Neuroscience DNS, University of Padova, Padova, Italy
Search for other papers by Mattia Barbot in
Google Scholar
PubMed
Search for other papers by Andrea Daniele in
Google Scholar
PubMed
Search for other papers by Marco Boscaro in
Google Scholar
PubMed
Laboratory Medicine, University-Hospital of Padova, Padova, Italy
Search for other papers by Mario Plebani in
Google Scholar
PubMed
Endocrine Disease Unit, University-Hospital of Padova, Padova, Italy
Search for other papers by Carla Scaroni in
Google Scholar
PubMed
authors have already suggested an intermediate phenotype – what we have called RAS – when assessing a patient’s HPA axis ( 17 ). From an endocrine perspective, hormone secretion occurs on a continuum: subclinical or intermediate scenarios are frequently
Search for other papers by M L M Barreto-Chaves in
Google Scholar
PubMed
Search for other papers by N Senger in
Google Scholar
PubMed
Search for other papers by M R Fevereiro in
Google Scholar
PubMed
Search for other papers by A C Parletta in
Google Scholar
PubMed
Search for other papers by A P C Takano in
Google Scholar
PubMed
practice is the subclinical condition, characterized by decreased TSH associated with T3 and T4 levels within the reference values ( 17 , 18 ). While overt hypothyroidism is characterized by elevated TSH levels and low circulating TH levels, subclinical
Search for other papers by Hiren Patt in
Google Scholar
PubMed
Search for other papers by Katrin Koehler in
Google Scholar
PubMed
Search for other papers by Sailesh Lodha in
Google Scholar
PubMed
Search for other papers by Swati Jadhav in
Google Scholar
PubMed
Search for other papers by Chaitanya Yerawar in
Google Scholar
PubMed
Search for other papers by Angela Huebner in
Google Scholar
PubMed
Search for other papers by Kunal Thakkar in
Google Scholar
PubMed
Search for other papers by Sneha Arya in
Google Scholar
PubMed
Search for other papers by Sandhya Nair in
Google Scholar
PubMed
Search for other papers by Manjunath Goroshi in
Google Scholar
PubMed
Search for other papers by Hosahithlu Ganesh in
Google Scholar
PubMed
Search for other papers by Vijaya Sarathi in
Google Scholar
PubMed
Search for other papers by Anurag Lila in
Google Scholar
PubMed
Search for other papers by Tushar Bandgar in
Google Scholar
PubMed
Search for other papers by Nalini Shah in
Google Scholar
PubMed
Age at onset** 8.6 years (1–60 years) 61 Age at diagnosis** AI 4 years (range: 0–23) 41 Age at onset** 6 years (range: 1–48) 65 Age at diagnosis** 5 (7.7%) 65 Prevalence of subclinical AI 16 (24
Search for other papers by Brenda Anguiano in
Google Scholar
PubMed
Search for other papers by Carlos Montes de Oca in
Google Scholar
PubMed
Search for other papers by Evangelina Delgado-González in
Google Scholar
PubMed
Search for other papers by Carmen Aceves in
Google Scholar
PubMed
do not translate into increased tumor growth in in vivo models, whereas T4 effects consistently stimulate tumorigenic processes. Epidemiological and clinical studies There is evidence that subclinical or overall hypothyroidism does not
Search for other papers by Yi Chen in
Google Scholar
PubMed
Search for other papers by Wen Zhang in
Google Scholar
PubMed
Search for other papers by Chi Chen in
Google Scholar
PubMed
Search for other papers by Yuying Wang in
Google Scholar
PubMed
Search for other papers by Ningjian Wang in
Google Scholar
PubMed
Search for other papers by Yingli Lu in
Google Scholar
PubMed
suggested that overt hyperthyroidism increases the rate of both bone formation and resorption ( 9 , 11 , 37 ), hypothyroidism results in a low bone turnover state ( 38 ), and subclinical hyper- and hypothyroidism are correlated with bone loss ( 39 , 40